Adam Koppel, Director, 10% Owner at Cerevel Therapeutics Holdings, Inc. (CERE), bought 664,586 shares at $10.30 ($6.8M) on 2020-11-09, disclosed to the SEC on 2020-11-12.
Open-market purchase of $6.8M CERE by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.30 | 332,293 | $3.4M | 50.0% |
| 2 | $10.30 | 332,293 | $3.4M | 50.0% |
| Total | $10.30 avg | 664,586 | $6.8M | 100% |
| Filing → |
| SWTX | SELL | 2021-03-11 | $103.7M | — | Filing → |
| DRNA | SELL | 2020-12-14 | $23.4M | — | Filing → |
| CERE | BUY | 2020-10-29 | $100.0M | — | Filing → |